Camacho, N, Van Loo, P, Edwards, S, Kay, JD, Matthews, L, Haase, K, Clark, J, Dennis, N, Thomas, S, Kremeyer, B, Zamora, J, Butler, AP, Gundem, G, Merson, S, Luxton, H, Hawkins, S, Ghori, M, Marsden, L, Lambert, A, Karaszi, K, Pelvender, G, Massie, CE, Kote-Jarai, Z, Raine, K, Jones, D, Howat, WJ, Hazell, S, Livni, N, Fisher, C, Ogden, C, Kumar, P, Thompson, A, Nicol, D, Mayer, E, Dudderidge, T, Yu, Y, Zhang, H, Shah, NC, Gnanapragasam, VJ, Isaacs, W
, Visakorpi, T, Hamdy, F, Berney, D, Verrill, C, Warren, AY, Wedge, DC, Lynch, AG, Foster, CS, Lu, YJ, Whitaker, HC, McDermott, U, Neal, DE, Eeles, R
, Bova, S & Cooper, CS 2017, '
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data',
PLoS Genetics, vol. 13, no. 9, e1007001, pp. e1007001.
https://doi.org/10.1371/journal.pgen.1007001